GET THE APP

Journal of Cell Science & Therapy

Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

Journal of Cell Science & Therapy : Citations & Metrics Report

Articles published in Journal of Cell Science & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Cell Science & Therapy has got h-index 15, which means every article in Journal of Cell Science & Therapy has got 15 average citations.

Following are the list of articles that have cited the articles published in Journal of Cell Science & Therapy.

  2021 2020 2019 2018 2017 2016

Year wise published articles

55 22 4 8 20 27

Year wise citations received

117 111 110 120 126 103
Journal total citations count 921
Journal impact factor 8.67
Journal 5 years impact factor 6.84
Journal cite score 8.35
Journal h-index 15
Journal h-index since 2017 12
Important citations

Expression and production of recombinant scorpine as a potassium channel blocker protein in escherichia coli.

Design and characterization of a novel tool for the antigenic enrichment of actinobacillus pleuropneumoniae outer membrane.

Widely applicable background depletion step enables transaminase evolution through solid-phase screening.

Teaching an old pet new tricks: tuning of inclusion body formation and properties by a mixed feed system in e. coli.

High-throughput recombinant protein expression in escherichia coli: current status and future perspectives.

Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?

Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters.

Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Challenges in drug discovery against tuberculosis

Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in east wollega, western ethiopia.

In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant mycobacterium tuberculosis.

Congenital malformations of the lung.

Pictorial review of false-positive results on radioiodine scintigrams of patients with differentiated thyroid cancer.

Date palm fruit extract ameliorated pancreatic apoptosis, endocrine dysfunction, and regulatory inflammatory cytokines in streptozotocin-induced diabetes in rats.

Metcam/muc18 promotes tumor progression and metastasis in most human cancers.

Dual role of metcam/muc18 expression in the progression of cancer cells

Human metcam/muc18 is a new diagnostic marker of and a driver for promoting and its specific sirnas, derived oligopeptides and antibodies be used for decreasing the malignant progression of prostate cancer.

Metcam/muc18: a novel tumor suppressor for some cancers.

Validating metcam/muc18 as a novel biomarker to predict the malignant potential of prostate cancer at an early stage by using a modified gold nanoparticles-based lateral flow immunoassay.

Metcam/muc18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: validation with western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay.

Relevant Topics

Top